Vishal Kapur, MD, FACC, FSCAI, RPVI

Original Contribution

Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions

04/15/2018

Samin K. Sharma , MD, FACC, FSCAI;

Hiroshi Ueda , MD;

Roxana Mehran , MD;

Nitin Barman , MD;

Yuliya Vengrenyuk , PhD;

Naotaka Okamoto , MD;

Annapoorna S. Kini , MD, MRCP, FACC;

Surbhi Chamaria , MD;

Takahiro Yoshimura , MD;

Samit Bhatheja , MD;

Samaneh Rabiei , MD;

Yonandy Barrientos , BS;

Joseph Sweeny , MD;

Vishal Kapur , MD, FACC, FSCAI, RPVI;

Usman Baber , MD;

The aim of the study was to compare the acute outcomes of Absorb bioresorbable vascular scaffolds (BVS) and second-generation drug-eluting stent implantation in routine clinical practice. There is a paucity of data regarding BVS use in a...

The aim of the study was to...

04/15/2018

Journal of Invasive Cardiology

Kapur Peripheral Artery Disease Figure 1

Peripheral Interventions

The Use of the Highlander™ 014 PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Disease

02/05/2024

Vishal Kapur , MD, FACC, FSCAI, RPVI;

We have been using the Highlander™ 014 PTA Balloon Dilatation Catheter since it came out in early 2023. It is a great balloon because of its deliverability, non-compliance, and ability to expand in a controlled, uniform manner.

We have been using the...

02/05/2024

Cath Lab Digest